CE Holdings CoTSE:4320 +0.23%75 EBITDA Margin % is 14.65% as of Mar. 2026, which is 46% above its 10-year median of 10.02. GuruFocus rates TSE:4320 with a GF Score™ of 75/100 and a GF Value™ of 円675.11 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 665 Healthcare Providers & Services companies, CE Holdings Co ranks better than 66.77% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. CE Holdings Co's EBITDA for the
six
months ended in Mar. 2026 was 円1,594 Mil. CE Holdings Co's Revenue for the
six
months ended in Mar. 2026 was 円10,877 Mil. Therefore, CE Holdings Co's EBITDA margin for the quarter that ended in Mar. 2026 was 14.65%.
CE Holdings Co (TSE:4320) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
CE Holdings Co EBITDA Margin % Related Terms
CE Holdings Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for CE Holdings Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4320 vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, CE Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CE Holdings Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CE Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where CE Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CE Holdings Co (TSE:4320) has a EBITDA Margin % of 14.65% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CE Holdings Co and its competitors. This is 46% above median its historical median of 10.02. Over the past decade, CE Holdings Co's EBITDA Margin % has ranged from 3.91 to 18.05. According to the industry distribution chart, CE Holdings Co ranks #221 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 33.2%.
Is CE Holdings Co's EBITDA Margin % too high?
CE Holdings Co's current EBITDA Margin % of 14.65% is 46% above median its 10-year median of 10.02. Over the past 10 years, this metric has ranged from a low of 3.91 to a high of 18.05. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. CE Holdings Co's value of 14.65% is 43.1% above this industry median. Based on the distribution chart, CE Holdings Co ranks #221 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CE Holdings Co has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CE Holdings Co's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CE Holdings Co ranks #221 out of 665 companies for EBITDA Margin %. This puts CE Holdings Co in the upper half of its industry. The industry median EBITDA Margin % is 10.24. CE Holdings Co's value of 14.65% is 43.1% above this benchmark. Historically, CE Holdings Co's own EBITDA Margin % has ranged from 3.91 to 18.05 over the past decade. While the company's 10-year median is 10.02 vs. the industry median of 10.24, CE Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CE Holdings Co's current EBITDA Margin % of 14.65% is 43.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CE Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CE Holdings Co's current EBITDA Margin % is 14.65%, which is 46% above median its own 10-year median of 10.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CE Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, CE Holdings Co (TSE:4320) is currently considered Significantly Overvalued. The stock's GF Value™ is 円675.11, compared to a current price of 円1,761.00 — trading 160.8% above its estimated fair value. The current EBITDA Margin % is 14.65%, which is 46% above median its 10-year median of 10.02 and 43.1% above the Healthcare Providers & Services industry median of 10.24. CE Holdings Co's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CE Holdings Co (TSE:4320), the current EBITDA Margin % is 14.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CE Holdings Co (TSE:4320) Overvalued in 2026?
Based on GuruFocus' analysis, CE Holdings Co stock appears to be overvalued.
The current stock price of 円1,761.00 is trading 160.8% above its estimated GF Value™ of 円675.11.
GuruFocus considers CE Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4320:
EBITDA Margin %: 14.65% (46% above median its 10-year median of 10.02)
GF Value™: 円675.11 vs. price of 円1,761.00 (160.8% above fair value)
Industry Position: 43.1% above the Healthcare Providers & Services median (#221 of 665)
No single metric tells the full story. See the TSE:4320 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CE Holdings Co Ltd is a Japan-based company engages in the development and sale of medical information systems focused on electronic medical record systems. It provides packaged software, medical information and accounting systems, electronic health record systems, and blood transfusion systems.
75GF Score
Get the complete analysis for TSE:4320
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4320 has been successfully added to your 
